Solid Tumor, Adult
293
89
120
77
Key Insights
Highlights
Success Rate
71% trial completion
Published Results
16 trials with published results (5%)
Research Maturity
77 completed trials (26% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.9%
32 terminated out of 293 trials
70.6%
-15.9% vs benchmark
0%
0 trials in Phase 3/4
21%
16 of 77 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 77 completed trials
Clinical Trials (293)
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
HMPL-A830 in Solid Tumors
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
PRE-ISPY Phase I/II Oncology Platform Program
A Study of DCR-STAT3 in Adults With Solid Tumors
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
A Monotherapy in Subjects With Advanced Solid Tumors
Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer
Ex Vivo Tumor Visualization and Resection Margin Assessment Using Topically Applied Fluorescent Imaging Agents
Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.